FDA panel takes up tough questions on J&J COVID-19 boosters

FDA panel takes up tough questions on J&J COVID-19 boosters

PIX 11

Published

WASHINGTON (AP) — U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson’s single-shot COVID-19 vaccine and when — and whether using a competing brand for the second dose might provide better protection. The push for boosters kicked off last month after the Food and Drug Administration authorized third doses of [...]

Full Article